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IgA nephropathy in one family. J. W. de GIas-Vos. R. T. Krediet, A.
G. Balk, W. R. Faber, andL. Arisz. Department of Medicine, Universi-
ty ofAmsterdam, Binnengacthuis, Amsterdam. IgA nephropathy was
diagnosed on renal biopsy specimens in two brothers, both presenting
with recurrent macroscopic hematuria. Patient A, 30 years old, was
suffering from attacks of macroscopic hcmaturia following upper respi-
ratory tract infections since his 9th year. Patient B. 42 years old,
presented with recurrent episodes of macroscopic hematuria since 5
years, either following upper respiratory tract infections or coinciding
with gastrointestinal symptoms such as abdominal pain, nausea, vomit-
ing, and diarrhea. Both patients were normotensive and had a normal
GFR. Serum IgA concentrations were increased in both patients.
Because of the findings mentioned above, a further investigation of the
family was done (father, mother, six sisters, and two brothers). The
purpose was to establish whether other members of the family had IgA
nephropathy, whether some of the "markers" of IgA nephropathy were
present in the family members (raised serum IgA level, positive
immunofluorescenee with anti-IgA antiserum in skin biopsies), and
finally whether a relationship could be demonstrated in the family
between the presence of the disease, the "markers," and I-ILA typing.
The following items were investigated in all the family members:
medical history, blood pressure, urinalysis for proteinuria and sedi-
ment, concentrations of plasma creatinine. immunoglobulins, and com-
plement components, C15 binding assay, and 1-ILA typing. No family
member had a positive history of renal disease. Blood pressure was
normal except in the father. Urinalysis, plasma concentrations of
creatinine, immunoglobulins, and complement components were nor-
mal in all. A raised serum IgA level was found in two family members,
the mother and one Sister (35 years old). HLA typing of the family is
shown in the following Table. There is no HLA identity in members
with a raised serum IgA level: as far as the B locus is concerned, patient
A and the mother share the HLA BW35, and patient B has B7 and
BW49 and is HLA-identical to his sister with a raised serum IgA. In the
four persons with a raised serum IgA and in one brother. IgA deposits in
cutaneous vessel walls (direct immunofluorescencc) were found to he
absent. In conclusion, clinically manifest lgA nephropathy did not
occur in other family members. Besides the patients, a raised serum IgA
level was found in two other family members. IgA deposits in cutaneous
vessel walls were not present in the patients nor the family members.
Finally, no relationship was observed between the disease, the "mark-
ers" and HLA typing.
Table: HLA typing
HLA typing
Effect of indomethacin on water and salt handling in sickle-cell anemia.
P. E. de Jong, L. T. W. de Jong-van den Berg. H. Sdiouten, A. J. M.
Donker, and L. W. Statius van Eps. Depart,nenl of Medicine, State
University, Groningen, The Netherlands, and Sr. Elisabeth Hospital,
Willemnstad, Curacao. Because sickle-cell nephropathy is characteriLed
by gross medullary pathology and because we recently found that renal
prostaglandins (PU) are important in maintaining a normal glomerular
filtration and renal plasma flow in sickle-cell anemia, we studied the
effect of indomethacin on water and salt handling during maximal water
deprivation and water loading. In both the control subjects and the
sickle cell anemia patients, indomethacin induced a fall in the fractional
excretion of sodium, potassium, and chloride, and an increase in the
fractional phosphate excretion in the water-deprived state as well as in
the water-loaded situation, The sodium retention after indomethacin is
therefore not due to an effect of indomethacin on the proximal tubule,
because in that part of the nephron sodium reabsorption is coupled with
phosphate reabsorption. An aldosteron-mediated effect of indometh-
acm is also excluded because sodium reabsorption was associated with
potassium reabsorption. We therefore conclude that indomethacin
stimulates sodium transport in the ascending limb of Henle's loop,
During water deprivation, indomethacin induced a rise in urinary
osmolality (U) from 830 to 1027 mOsm/kg water in the control
subjects. This is due to prostaglandin synthesis inhibition, for renal
prostaglandins are known to decrease the hydroosmotic action of
vasopressin. There was no change in in the sickle-cell anemia
group (419 and 409 mOsm/kg water, respectively). Because the concen-
trating defect in sickle cell anemia is not due to an unresponsiveness to
vasopressin, this points to a defect in trapping of solute in the medulla
of these patients. In the water-loaded control subjects, U() did not
change after indomethacin (59 and 63 mOsm/kg water, respectively).
This is due to the fact that vasopressin concentration in these maximally
hydrated subjects is suppressed and PG synthesis inhibition therefore
cannot influence waterreabsorplion. In the sickle-cell anemia patients,
however, there was a rise in Um from 42 to 125 mOsm/kg Water. This
suggests that vasopressin in these patients is not maximally suppressed,
which is in favor of an increased vasopressin production or a syn-
drome of resetting of the osniostat." Prostaglandin synthesis inhibition
in hydrated sickle cell anemia patients therefore can induce a dilutional
hyponatremia.
Transluminal dilatation of renal artery stenosis to preserve renal
function. D. de Zeeuw, A. J. Smnil, P. E. de Jong, S. J. Hoornije, A. J.
M. flanker, K. H. Sc/iuur, and U. K. van c/er 1-1cm. Departments of
Nephrology and Radiology, University Hospital, Groningen, The Neth-
erlands. Percutaneous transluminal angioplasty (PTA), a technique to
dilate stenotic lesions in arteries with the aid of a balloon-catheter, has
been successfully used in hypertensive patients with a renal artery
stenosis. Therefore, it seemed to us that this technique might also
improve or preserve renal function. Our results of PTA performed over
the last year in 20 consecutive patients with hypertension are as
follows. Sixteen patients underwent a successful PTA procedure. In the
other four patients, it was unsuccessful due to an occlusion of the
stenosis in two cases (occurring between diagnosis and PTA), no
dilation of the stenosis could be obtained in one patient, and the
procedure had to he stopped for signs of vagotonia in the fourth patient.
The mean followup of the 16 patients was 7.7 months (range, 2 to 12
months). Improvement of high blood pressure was obtained in seven
patients (four without and three with reduced medication). A remark-
able observation was the increase of GFR in eight patients after PTA,
where renal blood flow (ERPF) also increased in ten. The percent
increases of GFR and ERPF. respectively, are as follows for the groups
with different type of stenosis: 20 and 30% in eight patients with a
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Sex AgeA locus B locus
M 69 A2, A3 B7, BW44
F 65 Al, A3 BW49, BW35W 42 Al, A3 B7, BW49
F 40 A3 B7, BW35
M 39 A3 B7, BW35
F 38 Al,A2 BW44,BW49
M 36 Al, A3 B7, BW49
F 35 Al, A3 B7, BW49
F 34 Al, A3 B7, BW49
F 32 A2, A3 BW35, BW44
F 31 Al, A3 B7, BW49M 30 A2, A3 BW35, BW44
C locus DR locus
CW5 DRI,DR2
CW4 DRI,DR2
— DR2
CW4 DR! DR2
CW4 I)RI, l)R2
CWS DRI,DR2
— DR2
— DR2
— DR2
CW4, CW5 DRI
— DR2
CW4, CW5 DRI
apatients
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unilateral stenosis (four fibromuscular dysplasia. four arteriosclerotic),
18 and 36% in three patients with bilateral arteriosclerotic stenosis, and
115 and 36% in five patients with a unilateral arteriosclerotic stenosis
with an obstructed renal artery on the contralateral side. The PTA in the
latter group of five patients was not performed with great expectation
for lowering the blood pressure, but rather to prevent renal artery
occlusion of the one functioning kidney. in conclusion, it is shown that
preservation and/or improvement of renal function is another indication
besides treatment of high blood pressure to perform PTA in patients
with renovascular hypertension.
Salt sensitivity of the blood pressure in patients with renal insufficiency.
H. A. Koomans, J. C. Roos, P. Boer, G. G. Gerskes, andE. J. Dorhoit
Mees, University Hospital, Utrecht, The Netherlands. In 22 patients
with different degrees and kinds of renal insufficiency (RI) (Ce,, 3 to 75
mI/mm), we studied the effect of changed salt intake on blood pressure
(BP) and BP-determinats (for example, extraceliulair fluid volume
[ECVJ, blood volume [By], and plasma renin activity IPRA]). In all
patients these variables were measured twice: once during salt restric-
tion and once after increased salt intake. The salt sensitivity of the B.P
increased exponentially with decrease of CCr. No significant correlation
between BP and By, ECV, or PRA was found, or between BP and
products of log PRA with BV or ECV. Moreover, an increase of salt
intake caused these volume-renin products to decrease, whereas B]?
increased. This makes any positive correlation between volume and
renin products and BP unprobable. When patients were divided into
groups according to degree of RI, in group II (Ce,, 3 to 22 mI/mm, N =
13), a certain amount of salt-intake increase resulted not only in a larger
rise in BP, but also in By, compared with group I (Ccr, 32 to 75 mI/mm,
N = 9), whereas ECV and IV (interstitial fluid volume) rose similar in
both groups. Also PV/IV ratio behaved different in the two groups (P <
0.01); this ratio increased in group II and decreased in group I. Changed
salt intake caused similar PRA responses in the two groups. Conclu-
sions. (1) In these patients, the salt sensitivity of BP increased with an
increase of renal impairment. (2) This increase of salt sensitivity of BP
is accompanied by a shift of body fluids to the intravascular compart-
ment, which suggests a change of tissue capillary filtration forces in
patients with RI. (3) Inflexibility of renin-response was not responsible
for the increased salt sensitivity of BP in the patients with more severe
renal impairment. (4) Volume-renin products have only limited value as
BP-determinants.
IgG alloantibodies to class-I antigens mediate vasculonecrotic lesions in
renal allografts. G. D. Majoor and P. J. C. van Breda Vries,nan
Department of Immunology, Biomedical Center, University of Li,n--
burg, Maastricht, The Netherlands. How first-set renal allografts are
rejected is not clear but it has been suggested that IgG alloantibody may
contribute to or mediate the vasculonecrotic lesions in the graft.
Because Brown-Norway (BN) rats respond to class-I alloantigens
residing on LEW erythrocytes with tgM and IgG alloantibody respons-
es, this model offered the opportunity to examine the effect of preexist-
ing antibody to class-i alloantigens on the induction of vasculonecrotic
lesions in the graft, which are invariably observed in LEW kidneys
rejected by unmodified BN hosts. LEW kidneys inserted into unmodi-
fied BN recipients elicited both cellular immunity and 1gM as well as
IgG antibody responses to class-I and class-It alloantigens. LEW
kidneys inserted into BN recipients sensitized to produce 1gM antibody
to LEW class-I antigens elicited T-cell-mediated immunity as well as
1gM antibody to class-I and class-Il alloantigens. IgG antibody to class-II alloantigens was present in all instances; tgG alloantibody to class-LI,
alloantigens was present in 1 out of 7 recipients only; precisely the
kidney rejected by this recipient showed vasculonecrotic lesions.
Because the remaining kidneys were void of vasculonecrotic lesions,
these findings suggested that igG antibody to class-I, but not to class-Il
alloantigens mediated these lesions. To confirm this hypothesis LEW
kidneys were transplanted into BN recipients sensitized with LEW
erythrocytes to produce IgG antibody to LEW class-I antigens. LEW
kidneys inserted into these recipients failed to elicit early cellular
immunity, but were rejected in an accelerated fashion. Vasculonecrotic
lesions were observed in LEW kidneys rejected by these sensitized
hosts. These results suggest that in BN rats IgG antibody to LEW class-
I antigens mediates the vasculonecrotic lesions in LEW renal grafts and
that these lesions may develop in the absence of T-cell-mediated
immunity.
Intrinsic activation of prorenin. M. A. D. H. Schalekamp and F. H.
M. Derkx. Department of Internal Medicine I, Evasions University,
Rotterdam, The Netherlands. Two intrinsic activators of prorenin have
been identified—plasma kallikrein and plasmin. The generation of renin
by these activators in whole plasma was followed in vitro under optimal
conditions. Activation by kallikrein was maximal after 24 hours of
dialysis of plasma at pH 7.5 and 4° C for at least 16 hours. But, a small
deviation from the optimal pH in the first dialysis step resulted in
markedly reduced activation, so that the method is not suitable for
routine measurements of prorenin. Dialysis of plasma at pH 4.0 and 4°C
for 24 hours destroyed a,-antiplasmin, and 24 hours of incubation at 4°
C with urokinase (100 Ploug units/mI) after pH had been restored to 7.5
caused maximal activation by intrinsic plasmmn. The renin activity
generated by the intrinsic activators in a normal plasma pool was equal
to the activity generated under optimal conditions by Sepharose-bound
trypsin and pepsin. Activation with trypsin (0.25 mg/mI, 24 hoars of
incubation, pH 7.5, 4° C) was used for routine prorenin measurements.
Such measurements showed a fall in prorenin from 190 31 to 82 21
p.1.5/mI (mean 5EM, P < 0.025) within I hour after captopril (50 mg,
orally) in 8 patients with renovascular hypertension, whereas renia rose
from 81 19 to 420 83 p.U/ml (P < 0.001). Plasma prekallikrein
measured as amidolytic activity after activation by dextran sulphate fell
by 14.1 6.3% (P < 0.025), and a-antiplasmin measured as inhibitory
activity on Streptokinase-activated plasminogen fell by 13.4 5.2% (P
< 0.025). There were no significant changes in immunoreactive prekal-
likrein and plasminogen and in functionally measured kallikrein and
plasmin. The results are consistent with activation of prorenin in vivo
and with simultaneous activation of prekallikrein and generation of
plasmin with binding to cs2-antiplasmin.
Contribution of f-adrenoceptor blockade to the antihypertensive effect
of oral diazoxide. T. Thien, F. T. M. Huys,nans, E. L. M. Bonn, andR.
A. P. Koene. St. Radboudziekenhuis, Nijmegen. Combinations of -
adrenoceptor blocking drugs and directly acting peripheral vasodilators
are an established way to treat severe hypertension. The vasodilator-
induced increases in plasma renin activity (PRA) and heart rate (HR)
are suppressed by 13-blockers, thus making the vasodilators more
effective and tolerable for the patients. The aim of this study was to
investigate the contribution of the 13-blocker propranolol to the ypo-
tensive effectivity of the regimen with oral diazoxide. Eight patients
with severe hypertension (blood pressure [BP] without medication, 227/
145 mm Hg) were admitted to the clinic and put on a diet with a fixed
sodium content. As soon as they were in sodium balance, diazoxide
(100 mg, three times a day) was administered orally for 15 days. From
day 7 to II, propranolol (80 mg, three times a day) was added. BP was
measured with the Arteriosonde. HR and sodium excretion were
measured daily. Body weight (BW) and PRA were measured before
each change in the protocol. The results are given in the Table and
expressed as means SEM.
Diazoxide + propranolol
Control Diazoxide Day I Day 5 Diazoxide Control
HP, mm Hg
syst. 185 6 159 5 117 5 116 5 155 8 183 9
diast. 120 3 105 3 79±4 78 2 105±3 120 3
HR, beats/mm 77 2 93 2 74 4 69 3 92 2 74 2
11W, kg 64.4 4 65.8 4 — 66.5 4 66.9 4 —
PRA. ng/mIhr 5.0 1.1 7.8 1.3 — 3.0 0.4 6.0 1.2 —
Diazoxide alone induced a decrease in mean arterial pressure (MAP) of
12.9 2.4%, whereas propranolol decreased MAP further with 26.0
2.4%, leading to a total decrease of 36.1 2.1%. The effect of
propranolol was completely expressed at the first day of its addition.
The changes in MAP and PRA were significantly correlated during
diazoxide (r = —0.65), but further correlations between MAP, PRA,
and HR could not be found. The effect of propranolol is not only
additive, but a synergism between propranolol and diazoxide is suggest-
ed. Whether this synergism is due to the decrease in PRA or HR
remains uncertain. The antihypertensive effect was not antagonized by
the concomitantly occurring increase in BW.
Role of renal vasoconstriction in the pathogenesis of renal failure
induced by mercuric chloride. R. Vanholder, J. Vcrhanck, S. Rinç'oir,
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and N. Lameire. Renal Division, Department Internal Medicine,
University Hospital, De Pintelaan, 135, 11-9000 Ghent, Belgium. Acute
toxic renal failure was induced in dogs by the i.v. bolus injection of
mercuric chloride at a dose of 3 mg/kg. Within 3 hours, we observed an
almost parallel decrease in GFR and RPF by more than 40% and an
increase in urinary volume and urinary sodium excretion. Renal vaso-
constriction was then adequately prevented in this model by the
administration of the plasma volume expander Haemaccel alone or in
combination with the alpha-blocker phentolamine. L)espite stabilization
of RPF, GFR in the Haemaccel-phentolamine group fell at the same rate
as it did in the unpretreated dogs. In the Haemaccel® group, RPF
remained constant, and GFR decreased only by 18% 3 hours after
mercuric chloride administration compared with the control GFR value.
The less pronounced fall in GFR appeared essentially due to a rise in
GFR by more than 10% after Haemaccel before the mercuric chloride
was administered. Comparison of the GFR with the experimental pre-
mercuric chloride volume-expanded GFR revealed a fall in percentage
similar to the unpretreated animals. Finally, in both volume-expanded
groups, urine and electrolyte losses were more pronounced than they
were after mercuric chloride alone. It is concluded that renal vasocon-
striction apparently occurs concomitantly with a fall in GFR in the early
stage of mercuric chloride-induced ARF. However, these changes in
renal hemodynamics do not play an important pathogenetic role in the
generation of the ARF in this model.
Less aggressive rejection therapy and low-dose corticosteroids leading
to satisfactory cadaveric kidney graft survival and low morbidity rate. J.
P. van Hooff, Dept. Nephrology, University Hospital, Leiden, The
Netherlands. A less aggressive approach in the treatment of rejection
crises has been introduced since January 1979 in Leiden. The mainte-
nance dosage, consisting of azathioprin and prednisone, remained
unchanged. A low dosage of prednisone (25 mg) has been given 5 days
after transplantation and onwards. Compared with the period before
1979, this policy reduced by 50% the average dosage of corticosteroids,
given during the first 3 months to 39 patients. In spite of this lowered
dosage, the renal function and the graft survival have not worsened
after 1 year (80%) There was a considerable decline in the number of
complications; the percentage of patients without infections rose from
18% (1977 and 1978) to 55% (1978). The improvement in the results
could not be explained on the basis of a better match for the HLA (A +
B)and/or DR antigens. This change in policy was continued in 1980 and
is showing favorable results. Preliminary results indicate that 30% or
more of patients with a successful renal allograft did not receive a
rejection treatment at all.
